Blood Preparation Market size worth over $64bn by 2024

1
Blood Preparation Market size worth over USD 64
billion by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Blood Preparation Market

• Global Blood preparation market size will reach
  USD 64.3 billion by 2024, with more than 4
  growth, due to increasing geriatric population
  base and rising awareness of thrombosis and other
  blood disorders.
• U.S. dominates the industry contributing to share
  of over 90 of regional revenue.
• The blood preparation market size was valued at
  USD 19.1 billion in 2015 with growth expectations
  of 3.5 through the forecast period. 
• Germany and France will drive industry by
  collectively attributing to over 45 of regional
  revenue share by 2024.

3
Continued...

• France will grow at a faster rate of 2.3 while
  Germany will grow at 1.8 CAGR during the
  forecast period. 
• Japan have contributed to over 51 of regional
  revenue share with USD 4.3 billion in 2015 and
  expected to manifest robust growth of 5.9 during
  the forecast timeframe. 
• Key industry players are focusing on RD to
  develop cost effective novel technologies to
  consolidate their market position.

4
U.S. Blood Preparation Market Size, by Product,
2012- 2024 (USD Million)

5

Browse Full Market Research Report On Blood
Preparation Market _at_ http//bit.ly/2dKEyME
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/790 https//www.gminsights.com/request-sample/d
etail/49
6
360 Analysis

• Product Analysis
• Based on products, the industry is segmented into
  whole blood, components and derivatives. Whole
  blood segment dominated the industry contributing
  to the highest revenue share of over 48,
  followed by derivatives with over 34 of global
  blood preparation market share for 2015.
  Components will also manifest a decent forecast
  growth due to increasing use of packed red cells,
  leucocyte reduced RBCs, frozen plasma, platelet
  concentrate, cryoprecipitate and whole blood
  components.
• Regional Analysis
• U.S. will lead the industry due to increasing
  thrombocytosis disorder incidence, high patient
  awareness levels and presence of a robust
  healthcare infrastructure. FDA regulates
  collection, storage, and transport of blood and
  also works in collaboration with other agencies
  to implement health insurance for reimbursement
  for blood components.
• Competitive Market Share
• Major industry player comprises of Pfizer,
  GlaxoSmithKline, AstraZeneca, Leo Pharma,
  Celgene, Sanofi Aventis, Bristol-Myers, Baxter
  Healthcare, Shandong East Chemical.

7
Stay In Touch Website www.gminsights.com Soci
al Media